Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 109, Issue 7, 2999-3006, April 1, 2007
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study
Blood Kornblau et al. 109: 2999

Supplemental materials for: Kornblau et al, Vol 109, Issue 7, 2999-3006

Files in this Data Supplement:

  • Table S1. Pravastatin + idarubicin toxicity (PDF, 124 KB) -
    ALT SGPT indicates alanine aminotransferase serum glutamic pyruvic transaminase; AST SGOT, aspartate aminotransferase serum glutamic oxaloacetic transaminase; CNS, central nervous system; NOS, not otherwise specified; CPK, creatine phosphokinase; DIC, disseminated intravascular coagulation; GOT, glutamic oxaloacetic transaminase; GGT, -glutamyltransferase; GI, gastrointestinal; GU, genitourinary; GR, grade; ANC, absolute neutrophil count; PT, patient; AGC, absolute granulocyte count; PTT, partial thromboplastin time; EMBOL, embolism; VASC ACC, vascular accident.




This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020